"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

August 3, 2020 updated by: Sibel Gayretli Atan, Istanbul University

The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

Study Overview

Detailed Description

Hemiplegic shoulder pain is a common symptom. Our aim in this study is to investigate the relationship between hemiplegic shoulder pain and balance and upper extremity functions.

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Istanbul
      • Bahçelievler, Istanbul, Turkey, 34180
        • Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

hemiplegic shoulder pain

Description

Inclusion Criteria:

  • Having had a cerebrovascular accident
  • Ages ranging from 40 to 75
  • Right or left hemiplegic
  • Without mental problems
  • Cooperative
  • According to Brunnstrom staging, upper extremity stage 1-2-3-4-5

Exclusion Criteria:

  • who do not want to be evaluated
  • Under the age of 40 and over the age of 75
  • Non-cooperative
  • Another orthopedic shoulder problem
  • Newly operated patients will not be included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper Extremite Fugl-Meyer Assessment (UA-FMA)
Time Frame: 1 day (Evaluation will be done once)
Upper Extremite Fugl-Meyer Assessment (UA-FMA) is a scale that evaluates upper extremity functionality. The total score is at least 0 and at most 66 and the high scores are positively correlated with the normal function.
1 day (Evaluation will be done once)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
McGill Melzack Pain Questionnaire
Time Frame: 1 day (Evaluation will be done once)
McGill Melzack Pain Questionnaire is used to assess pain. High scores are positively correlated with pain.
1 day (Evaluation will be done once)
Short Form- 36
Time Frame: 1 day (Evaluation will be done once)
SF-36 will be used to assess physical and mental health-related quality of life. The total score is at least 0 and at most 100, and the high scores are positively correlated with high quality of life.
1 day (Evaluation will be done once)
Berg Balance Scale
Time Frame: 1 day (Evaluation will be done once)
Berg balance scale is a scale used to evaluate balance.The total score is at least 0 and at most 56, and the high scores are negatively correlated with high quality of life.
1 day (Evaluation will be done once)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sibel Gayretli Atan, Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 5, 2020

Primary Completion (ACTUAL)

July 22, 2020

Study Completion (ACTUAL)

August 3, 2020

Study Registration Dates

First Submitted

March 1, 2020

First Submitted That Met QC Criteria

March 2, 2020

First Posted (ACTUAL)

March 3, 2020

Study Record Updates

Last Update Posted (ACTUAL)

August 4, 2020

Last Update Submitted That Met QC Criteria

August 3, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegic Shoulder Pain

Clinical Trials on "The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

3
Subscribe